Evaluating the Re-Identification Risk of a Clinical Study Report Anonymized Under EMA Policy 0070 and Health Canada Regulations

Trials - United Kingdom
doi 10.1186/s13063-020-4120-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Evaluating Legal Certainty Under Insolvency Regulations of the European Union

International Review of Law
2020English

Problem Definition and Re-Evaluating a Policy: The Real Successes of a Regeneration Scheme

Critical Policy Studies
SociologyPublic AdministrationPolitical Science
2012English

Definition of a Retrospective Health Information Policy Based on (Re)Use Study

English

2014 Ontario Child Health Study Findings: Policy Implications for Canada

Canadian Journal of Psychiatry
PsychiatryMental Health
2019English

Evaluating the Public Health Impact of Health Promotion Interventions: The RE-AIM Framework.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1999English

The Re-Identification Risk of Canadians From Longitudinal Demographics

BMC Medical Informatics and Decision Making
Health PolicyHealth Informatics
2011English

A Policy Model to Analyze Macroprudential Regulations and Monetary Policy

Canadian Journal of Economics
EconomicsEconometrics
2018English

Ondansetron for Nausea and Vomiting in Pregnancy: Re-Evaluating the Teratogenic Risk

Obstetric Medicine
GynecologyObstetrics
2020English

Neonatal Cytokines and Chemokines and Risk of Autism Spectrum Disorder: The Early Markers for Autism (EMA) Study: A Case-Control Study

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy